在患有血管疾病的个体中,摄入量和发生心房动
Linda S Johnson1,2, Andrew Mente2, Philip Joseph2
1Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
JAMA network open
|July 11, 2024
概括
高摄入量与心血管疾病或糖尿病患者心房动 (AF) 风险增加有关. 减少的摄入量,特别是那些摄入量高的人,可能有助于预防AF.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學.
- 流行病学 流行病学
背景情况:
- 前性队列研究经常报告尿液分泌与心血管事件/死亡之间的J形关联.
- 了解摄入量与心房动 (AF) 之间的特定关系对于心血管健康管理至关重要.
研究的目的:
- 调查估计每日摄入量与心房动 (AF) 发生率之间的关联.
- 确定高风险人群中消耗水平和AF风险之间是否存在J形关系.
主要方法:
- 利用了来自ONTARGET和TRANSCEND试验中27,391名患有血管疾病或高风险糖尿病的参与者的数据.
- 估计每日摄入量使用川崎配方从早晨的禁食尿样.
- 采用多变量调整的考克斯回归和立方斜线来建模摄入量和事件AF之间的关联,平均随访时间为4.6年.
主要成果:
- 在摄入量和AF风险之间观察到J形关联 (非线性P = .03).
- 8g/d或更高的摄入量与与4-5.99g/d相比,增加了32%的发生性AF风险.
- 超过6g/d的摄入量显示每增加1g/d的AF风险增加10%,而较低摄入量水平没有进一步降低风险.
结论:
- 这项队列研究证实了心血管疾病或糖尿病患者的摄入量和AF风险之间的J形关联.
- 旨在降低AF预防的摄入量的干预措施应优先考虑饮食中摄入量高的个体.
- 这些发现表明,针对高饮食是减少与相关的AF风险的最有效策略.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Antihypertensive Drugs: Angiotensin II Receptor Blockers
695
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
695
Antihypertensive Drugs: Direct Renin Inhibitors
546
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
546
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
822
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
822
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K


